Project Grant HT94252410808
Award Date
10/1/24
Completion Date
9/30/27
Dollars Obligated
$716K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Baltimore, MD 21218, USA
Similar Awards
The Department of Defense's Defense Health Agency awarded a $900,625.00 Project Grant to The Johns Hopkins University on July 1, 2024 under the Military Medical Research and Development program (CFDA 12.420). The 3-year grant will fund research on "The Role of Organismal Aging and the Plantar Skin Microenvironment in Acral Melanoma Progression." This research aims to investigate how biological aging and the skin microbiome impact the progression of acral melanoma, a rare form of skin...
This $867,712 Project Grant award from the Department of the Army Medical Command (under the Military Medical Research and Development program, CFDA 12.420) supports advanced biomedical research at The Johns Hopkins University focused on transforming healthcare for military service members and the general public. The research aims to investigate effective treatment of pancreatic cancer through systemic chemotherapy combined with alpha-particle radiotherapy, with a focus on early hepatic...
The Johns Hopkins University was awarded a $647,632 Project Grant from the Defense Health Agency under the Military Medical Research and Development program. The grant will fund a research project from August 1, 2023 to July 31, 2026 to leverage a precision medicine platform to predict novel therapies for malignant peripheral nerve sheath tumors. Through the support of basic, applied, and advanced biomedical research, the Military Medical Research and Development program aims to transform health...
The Department of Defense's Defense Health Agency awarded a $1,194,425 Project Grant to The Wistar Institute of Anatomy and Biology to support a 3-year research project titled "DEVELOPING RATIONAL APPROACHES FOR ACRAL MELANOMA" under the Military Medical Research and Development program (CFDA 12.420). The grant will fund basic, translational, and clinical research aimed at developing new treatments and advancing scientific understanding of acral melanoma, a rare form of skin cancer. As...
The Johns Hopkins University received a three-year, $651,158 Project Grant award from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will support the university's research into early assessment of treatment response in breast cancer patients undergoing neoadjuvant therapy using an automated liquid biopsy-breast cancer methylation assay. The Military Medical Research and Development program aims to transform military...
This $646,252 Project Grant award from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420) supports research to uncover cell intrinsic and extrinsic factors governing melanoma dormancy at single-cell resolution. The primary awardee, Trustees of Boston University, will conduct this advanced biomedical research. The University of Virginia will provide academic and technical resources, including experiments generating and validating...
The federal Project Grant award in the amount of $178,000.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant is funding research at the Dana-Farber Cancer Institute, Inc. (DFCI) in Boston, Massachusetts to target the Merkel ST-MYCL-EP400 complex in Merkel cell carcinoma. The research aims to develop innovative approaches to the understanding, detection, and treatment of this rare and aggressive form of skin cancer...
The Department of the Army Medical Command awarded a $1.03 million Project Grant to The Johns Hopkins University under the Military Medical Research and Development program (CFDA 12.420) for the period of July 1, 2022 to June 30, 2025. The grant supports the integration of germline and somatic immunogenomic analyses to investigate African American prostate cancer. Specifically, the university will conduct basic, applied, and advanced biomedical research to transform military and public health...
This $1,473,750 federal Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports The Johns Hopkins University's research study on "The Immunomodulatory Impact of Chemotherapy When Combined with PD-1 Blockade in Resectable Lung Cancer." The 3-year grant, running from September 1, 2024 to August 31, 2027, aims to investigate innovative immunological interventions for treating lung cancer in military service...
This $1,637,500 federal Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research conducted by The Johns Hopkins University to target specific PARP1 inhibition for breast cancer treatment. The award, which began on July 1, 2024 and will be completed by June 30, 2027, will enable the university to conduct innovative scientific studies ranging from basic laboratory research to advanced clinical trials focused on improving...